Cara Therapeutics

April 3, 2017April 3, 2017

Cara’s Intravenous Therapy CR845 Reduces Itching in Uremic Pruritus Patients, Trial Finds

News

Cara Therapeutics announced that treatment with its intravenous drug CR845 reduced itching and improved quality of life in patients suffering from uremic pruritus (UP) associated with chronic kidney disease. These results come ... Read more

December 2, 2016

Cara Therapeutics Ends Enrollment in Part A of CKD-associated Pruritus Study

News

Cara Therapeutics recently announced the conclusion of patient enrollment in the three-dose part of its Phase 2/3 clinical trial evaluating the effectiveness and safety of intravenous CR845 in dialysis patients ... Read more